Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-3 of 3
Keywords: Fasting
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Dubai Diabetes Endocrinol J (2023) 29 (1): 55–61.
Published Online: 12 January 2023
...Bachar Afandi; Mohamed Hassanein; Shehla Shaikh; Gamal Ibrahim; Monira Alarouj Introduction: A novel clinical calculator was developed to assist physicians in classifying the risk for individuals with diabetes planning to observe fasting during the holy month of Ramadan. The aim of this study...
Journal Articles
Mohamed Hassanein, Abdulqawi Almansari, Ebtesam Ba-Essa, Fatheya F. Alawadi, Hussein ElBadawi, Rakesh Kumar Sahay, Rayaz Malik, Rohana Abdul Ghani, Salah Abusnana, Shehla Shaikh, Sueziani Binte Zainudin, Tarik Elhadd, Yousef AL Saleh
Dubai Diabetes Endocrinol J (2022) 28 (4): 131–135.
Published Online: 21 December 2022
... (GLP-1RAs) are proven to be well tolerated and efficacious in people with type 2 diabetes mellitus (T2DM) fasting during Ramadan. The first oral GLP-1RA semaglutide, also indicated for the treatment of T2DM, has specific dosing instructions to optimize treatment exposure, which may need to be altered...
Journal Articles
Dubai Diabetes Endocrinol J (2022) 28 (3): 102–111.
Published Online: 04 July 2022
...Mohamed Hassanein; Saud Al Sifri; Fatheya Al Awadi; Thamer Alessa; Ashraf Shaaban Introduction: The safety and effectiveness of gliclazide modified release (MR) in patients with type 2 diabetes mellitus (T2DM) who fasted during Ramadan were previously published. Here, we carried out a regional...
